REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol

OBJECTIVE: Long-term oxygen therapy (LTOT) during 15 h/day or more prolongs survival in patients with chronic obstructive pulmonary disease (COPD) and severe hypoxemia. No randomized controlled trial has evaluated the net effects (benefits or harms) from LTOT 24 h/day compared with 15 h/day or the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundh, Josefin, Bornefalk-Hermansson, Anna, Ahmadi, Zainab, Blomberg, Anders, Janson, Christer, Currow, David C., McDonald, Christine F., McCaffrey, Nikki, Ekström, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390558/
https://www.ncbi.nlm.nih.gov/pubmed/30808321
http://dx.doi.org/10.1186/s12890-019-0809-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390558/
https://www.ncbi.nlm.nih.gov/pubmed/30808321
http://dx.doi.org/10.1186/s12890-019-0809-7

Ejemplares similares